Calanus finmarchicus Oil

Evidence: Limited
Fatty-acid

Useful mainly for people seeking a novel marine omega-3 source; preliminary interest for metabolic health.

Quick decision guide

May help most

people seeking a novel marine omega-3 source; preliminary interest for metabolic health

Common dosing range

~1-2 g/day in studies

When to expect effects

Weeks to months

Watch out for

shellfish/crustacean-type allergen; clinical evidence is preliminary

What is it

Calanus oil is extracted from Calanus finmarchicus, a small copepod (zooplankton) harvested in the North Atlantic. Its omega-3 fatty acids (EPA, DHA, and stearidonic acid) are bound mainly as wax esters rather than triglycerides or phospholipids, and it naturally contains the antioxidant astaxanthin.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You want a distinctive marine omega-3 (wax-ester bound) source
You're comfortable being an early adopter of thin evidence

Probably skip if

You have a shellfish/crustacean allergy
You want established, well-proven benefits
You need a high, measured EPA+DHA dose at low cost

Evidence at a glance

GoalEvidenceEffectBest fitTime
metabolic/body-composition supportLimitedSmall, preliminaryadults with overweight/abdominal adiposity (early study populations)Weeks to months

Evidence for 1 use

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

metabolic/body-composition support

Biomarker support
Limited

Small RCTs, several from groups linked to the producer, suggest calanus oil may modestly reduce abdominal fat or improve some metabolic markers, possibly via its wax-ester omega-3s and astaxanthin. Trials are few, small, and not independently replicated, so findings should be treated as preliminary. Reported endpoints are largely biomarkers and body-composition measures rather than clinical outcomes.

Effect size: Small, preliminary
Time to effect: Weeks to months
Best fit: adults with overweight/abdominal adiposity (early study populations)

Bottom line: Early, small trials hint at modest metabolic effects, but the evidence is too thin to rely on.

Evidence is mixed

Positive signals come mainly from a small number of related research groups and have not been independently confirmed at scale.

How to take it

Typical dose
~1-2 g/day of calanus oil
Timing
With a meal
With food
With food containing fat
How long to try
12+ weeks for any metabolic readouts

What to track

  • waist circumference/body fat
  • fasting glucose or lipids
  • GI tolerance

Safety

Common side effects

mild GI upset, fishy aftertaste

Who should avoid it

  • people with shellfish/crustacean allergy (copepods are crustaceans)

Pregnancy & breastfeeding

Not studied in pregnancy; avoid without medical advice.

Interactions

anticoagulant and antiplatelet drugsMinor

As a source of omega-3 fatty acids, theoretical additive effect on bleeding time

Choosing a product

Look for

  • States omega-3 (EPA/DHA/SDA) content per serving
  • Sustainability/harvest certification
  • Third-party purity testing

Be skeptical of

  • 'Melts belly fat'
  • 'Superior to all other omega-3s'

References by claim

metabolic/body-composition support

  • Wasserfurth et al., 2020PMC (2020) link

Track Calanus finmarchicus Oil with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.